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Abstract
Background: Scoliosis is a common spinal deformity that occurs often during adolescence. Previous studies
suggested that adolescent idiopathic scoliosis (AIS) patients can have various aspects of their lives being affected,
due to disease presentation and/or treatment received. It is important to define a reliable instrument based on
which the affected patients’ health-related quality of life can be assessed. This study aims to assess the validity,
reliability and sensitivity of the EuroQoL 5-dimension 5-level (EQ-5D-5L) in Chinese patients with AIS.
Methods: Adolescent idiopathic scoliosis patients of Chinese descent were prospectively recruited to complete
both the traditional Chinese versions of the EQ-5D-5L and the refined Scoliosis Research Society-22 (SRS-22r)
questionnaires. Patients’ demographic profiles and corresponding clinical parameters including treatment
modalities, spinal curve pattern and magnitude, and duration of bracing were recorded. Telephone interviews were
then conducted at least two weeks later for the assessment of test-retest reliability. Statistical analysis was
performed: construct validity of the EQ-5D-5L domains were assessed using Spearman’s correlation test against the
SRS-22r; whereas intra-class correlation coefficient (ICC) was used to assess the test-retest reliability, and agreement
over the test-retest period was expressed in percentages. Also, the sensitivity of the EQ-5D-5L in differentiating
various clinical known groups was determined by effect size, independent t-test and analysis of variance.
Results: A total of 227 AIS patients were recruited. Scores of domains of the EQ-5D-5L correlated significantly (r: 0.57-0.74)
with the scores of the SRS-22r domains that were intended to measure similar constructs, supporting construct validity. The
EQ-5D-5L domain responses and utility scores showed good test-retest reliability (ICC: 0.777; agreement: 76.4 -98.1 %).
Internal consistency was good (Cronbach’s α: 0.78) for the EQ-5D-5L utility score. The EQ-5D-5L utility score was sensitive in
detecting differences between subjects who had different treatment modalities and bracing duration, but not for curve
pattern and its magnitude.
Conclusions: The EQ-5D-5L is found to be a valid, reliable and sensitive measure to assess the health-related quality of life
in Chinese AIS patients. This potentiates the possibility of utilizing the EQ-5D-5L to estimate AIS patients’ health-related
quality of life, based on which the outcome of various treatment options can eventually be evaluated.
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Background
Scoliosis can be defined as a torsional spinal deformity,
in which the 3-dimensional geometry of the spine is
changed as a result of the combination of a translation
and rotation of variable number of vertebrae [1]. A ma-
jority of scoliosis is idiopathic and presents during ado-
lescence [2]. These patients with adolescent idiopathic
scoliosis (AIS) often present at variable curve magni-
tudes upon the first consultation and the curvature may
progress depending on the initial magnitude of curve
and status of skeletal maturity [3, 4]. The natural history
may also be affected by the introduction of any interven-
tion such as bracing before patients have reached skel-
etal maturity [5].
Besides the obvious radiographic differences in curve
magnitude, any treatment option can only truly demon-
strate benefit with superior patient-perceived outcome
measures. It is thus necessary to explore patients’ quality
of life. This is particularly important in AIS as previous
reports suggest that these patients experience relatively
poorer psychosocial functioning, self-perception of body
image, and health-related quality of life versus their non-
scoliotic peers [6]. When compared to their healthy
peers, AIS patients undergoing brace treatment may be
negatively affected in terms of psychosocial well-being
[7, 8]. Among various treatment modalities, AIS patients
with observation may experience a better score for body
image and quality of life than braced patients [9, 10]. On
the contrary, there are studies suggesting that there are
no differences in the quality of life between patients
treated with bracing and those under monitoring only
[11]; and even between braced/operated patients and the
general population in the long-term [12].
The reported evidence here suggest that AIS can affect
the health-related quality of life (HRQOL) of the affected
adolescents, which can be variable depending on the se-
verity of disease presentation, and different treatment
options. With the appropriate indications for treatment in
place, healthcare providers may be able to improve the
HRQOL of AIS patients with timely interventions. For in-
stance, patients may benefit from interventions, such as
psychological therapy accompanying the administration of
bracing. This can improve the self-perception of body
image, which is a barrier to the initiation and continuation
of brace treatment [13], and ultimately enhances brace
compliance. Therefore, a reliable instrument tailored for
AIS is desirable to assess the physical ability, psychological
well-being and psychosocial functioning of these patients.
Moreover, the instrument serves as an indicator of how
these factors can impact the HRQOL of the AIS popula-
tion in general.
In fact, validated outcome measurements, together
with systemic reviews based on clinical trials, form the
scientific framework of evidence-based medicine (EBM),
which is used to guide clinical practice [14]. Evidence-
based medicine can be defined as an integration of the
best research evidence with clinical expertise and patient
values [15]. Ultimately, the goal of EBM is to provide
scientific information to clinicians to improve the quality
of healthcare by taking into account cost, ethics and
safety. Adoption of EBM to clinical practice depends on
the quality of evidence (i.e. from the validated outcome
measurements and systemic reviews on clinical trials),
and the willingness of the clinician to apply that evi-
dence to their practice [14]. Therefore, it is of utmost
importance to utilize an effective and appropriate object-
ive outcome measure for the assessment of patient
values and their quality of life. This can be accomplished
by the use of structured questionnaires to measure an
individual's perception of his/her physical, mental and
social ability to function [16].
Several systematic reviews [6, 17, 18] have summarized
that various instruments can assess the HRQOL of AIS
patients, and are primarily classified into two main cat-
egories: generic and condition-specific instruments. As
generic instruments capture a very broad range of health
statuses, condition-specific measures specifically assess
the special states and functions of a particular disease in
greater details than generic measures [16], with more re-
sponsiveness in detecting important changes over time,
and better sensitivity in discovering subtle effects of in-
terventions [10, 19]. However, disease-specific instru-
ments can only focus on known and anticipated
consequences [20, 21]. These instruments do not allow
obvious comparisons across populations of different dis-
eases, and between outcomes of different treatments for
patients with various health problems [16]. On the con-
trary, generic measures give health state utility values
that permit comparisons between patient groups [22], or
cost-effectiveness comparisons between different treat-
ment modalities for various diseases [23]. It can be used
to generate ‘normative values’ with which patients with
health problems can be compared [16]. Despite generic
measures may have value in detecting unexpected posi-
tive or negative effects of an intervention [24], its non-
specific nature can have reduced sensitivity in detecting
changes caused by interventions in relevance to any one
illness, especially in clinical trials. Generic measure allow
broad applicability across specialties or populations but
is multi-domain. This poses a risk of results misinter-
pretation if improvement in only a single domain is re-
ported as general improvement in quality of life and may
distort general scoring [25].
The refined Scoliosis Research Society-22 (SRS-22r)
was originally developed for aiming at measuring spine-
specific HRQOL of adolescent or adult patients with
scoliosis. Given that two domains (self-image and satis-
faction with management) of the SRS-22r are relevant
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and only specific to scoliosis patients, the measured con-
structs in the SRS-22r instrument may not fully overlap
with generic instruments. Previous studies [26, 27] ad-
ministering both the generic and spine-specific instru-
ments suggest that self-image and satisfaction with
management are poorly correlated with domains of gen-
eric instruments. This is the case with commonly used in-
struments like the EuroQoL 5-dimension (EQ-5D) [26]
and the 36-Item Short Form Health Survey (SF-36) [27],
whose domains do not relate well to spine-specific instru-
ments. Furthermore, generic instruments allow head-to-
head comparisons among different health conditions, par-
ticularly for the EQ-5D, as a preference-based measure
which enables calculation of quality-adjusted life years
(QALYs) in economic evaluation. As such, the spine-
specific HRQOL instruments may not supersede the gen-
eric instruments among AIS patients. Therefore, the aim
of the present study was to assess the validity, reliability
and sensitivity of the EQ-5D in Chinese AIS patients.
Methods
Subjects and setting
Convenience sampling of patients with histological proof
of AIS patients of Chinese ethnicity were recruited be-
tween August and October 2015 at the Duchess of Kent
Children’s Hospital in Hong Kong. Exclusion criteria in-
cluded patients with non-idiopathic scoliosis (congenital/
neuromuscular), who could not understand traditional
Chinese, refused to participate or were physically or men-
tally unfit. This study was ethically approved by the local
institutional review board.
Subjects who consented were asked to answer a struc-
tured questionnaire which consisted of the EQ-5D-5L
questionnaire (Hong Kong (traditional Chinese) EQ-5D-
5L version) and the traditional Chinese version of the
SRS-22r questionnaire. Half of the subjects were asked
to fill in and complete the SRS-22r questionnaire first
prior to being given the EQ-5D-5L, and the other half
were given the questionnaires in the reversed order.
Demographic data of patients and clinical data at the
time of visit were collected. A spine surgeon performed
the consultation and radiographic measurement as
usual, without prior knowledge of the conduction of
questionnaires. The Cobb angle [28] was measured on
the whole spine radiograph taken at that appointment
and were recorded. Also, the curvatures were classified
using the modified Lenke classification system [29]
which included six curve types: type 1 (main thoracic),
type 2 (double thoracic), type 3 (double major; thoracic
curve larger than lumbar curve), type 4 (triple major),
type 5 (thoracolumbar or lumbar curve), type 6 (double
major; thoracolumbar or lumbar curve larger than thor-
acic curve). Treatment modalities of whether patients
were undergoing observation, bracing, bracing followed
by surgery and those who had corrective surgery but
presented for regular review, were retrieved from sub-
jects' medical records.
All subjects were scheduled for a telephone interview
conducted by a single research personnel in a random
order, at least two weeks after their baseline interview.
This follow-up interview consisted of administering the
two questionnaires in the same order as at baseline. This
was structured to assess the test-retest reliability of our
study instruments.
Study instruments
EuroQoL 5-dimension 5-level (EQ-5D-5L) (Additional file 1)
The EQ-5D-5L is a generic health status measure devel-
oped by the EuroQol Group for measurement of quality of
daily life [30], providing descriptions of five dimensions of
health status. It is an instrument enabling a quantitative ex-
pression of the individual’s values and preferences regarding
overall health status [16, 31]. Being a utility measure, the
EQ-5D-5L plays an important role in both clinical and eco-
nomic appraisal, for instance in the assessment of social
value of different healthcare interventions by means of
cost-utility analysis[32], and its possible use as decision-aids
in individual patient care where patients having difficulties
deciding between treatment options [33].
The EQ-5D-5L has five domain scales (mobility, self-
care, usual activities, pain and discomfort, and anxiety
and depression) and five levels for each domain. Since
the Chinese-specific EQ-5D-5L value set / tariff is cur-
rently not available, we applied a two-step indirect ap-
proach to estimate the EQ-5D-5L scores applicable for
Chinese population, as adopted in previous studies [34].
The first step was the application of an indirect interim
mapping method [35]. The EQ-5D-5L health status was
transformed to the EQ-5D-3L health status according to
the transition probability matrix. Finally, the EQ-5D-3L
health status were scored according to a recently devel-
oped Chinese-specific the EQ-5D-3L value set ranging
from −0.149 for the worst health status (‘33333’) to 1 for
the full health (‘11111’) [36]. Since the EQ-5D-5L has 5
items, each digit in the five digit codes refers to the sta-
tus of each dimension, ranging from 1 for no problem,
to 5 for severe problem. For example, the five digit of
‘11111’ implies to a health status with no problems in
the 5 dimensions, scoring 1 being the best score with no
problem in each domain listed in the order of: mobility
= 1, self-care =1, usual activities =1, pain and discomfort
=1, anxiety and depression =1. A higher score in the
EQ-5D-5L indicated better HRQOL.
Refined Scoliosis Research Society-22 (SRS-22r)
(Additional file 2)
The SRS-22r is a simple and valid spine-specific health-
related quality of life instrument developed by the
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Scoliosis Research Society. It provides an insight into the
idiopathic scoliosis patient’s perception of his/her condi-
tion [37]. The SRS-22r is a refinement of the previous
SRS-22 questionnaire, with a minor revision (i.e. Question
18- related to going out, and a concern over Question 15
– related to financial considerations), it makes gathering
of longitudinal HRQOL information from adolescence
through adulthood possible [38].
The SRS-22r had 22 items grouped into five sub-
scales. The domains covered were: Function (5 items),
Pain (5 items), Self-image/appearance (5 items), Mental
Health (5 items) and Satisfaction with Management (cur-
rently undergoing or had been performed – 2 items). The
sum of domain scores gave the overall SRS-22r total score
with a range from 0 to 5. Patients were asked to indicate
the stage of undergoing treatment, whether they were
present for initial consultation, regular follow-up without
intervention, bracing, immediately pre-operative, or postop-
erative. The SRS-22r questionnaire had been previously val-
idated in the Hong Kong Chinese scoliosis population [39].
Statistical analysis
Descriptive statistics including mean, standard deviation
(±SD) and percentage of floor and ceiling of domain and
total scores were calculated. At least 15 % of patients
achieving the lowest or highest possible score was con-
sidered as presence of floor or ceiling effect, respectively
[40]. The construct validity of the EQ-5D-5L domain
was assessed using Spearman’s correlation test against
the SRS-22r domain scores holding similar constructs.
The internal consistency was assessed by Cronbach’s
alpha using a value >0.7 to indicate adequate internal
consistency [41]. Test-retest reliability was assessed by
examining the weighted kappa for five individual domain
responses and the intra-class correlation coefficient
(ICC) for the EQ-5D-5L score over the 2-week period.
An ICC of ≥0.7 was used to indicate good reproducibil-
ity of the EQ-5D-5L score [40]. A weighted Kappa of
<0.2 was interpreted as poor agreement of individual do-
main responses between two assessments, 0.21-0.4 as
fair, 0.41-0.6 as moderate, 0.61-0.8 as good and ≥0.8 as
very good [42].
The sensitivity of the EQ-5D-5L score was determined
by performing known group comparisons by effect size,
independent t-test and analysis of variance, where ap-
propriate. Cohen's effect size was calculated as the dif-
ference between mean scores, divided by pooled SD.
Comparisons of known clinical groups were (i) Observa-
tion treatment versus bracing or surgery; (ii) Observa-
tion treatment versus bracing only; (iii) Bracing versus
surgery; (iv) Duration of bracing: for less than, or more
than one year; (v) Curve Pattern: Modified Lenke Classi-
fication type 1/2 (thoracic curves only) versus type 5
(lumbar curves only) versus type 3/4/6 (thoracic and
lumbar curves); (vi) Curve magnitude: Cobb angle ≤40°
versus >40°.
Data analyses were conducted using SPSS Windows
23.0 (IBM SPSS Inc., Chicago, IL, USA) and STATA
version 13.0 (StataCorp LP. College Station, Texas, U.S.).
P-value <0.05 was statistically significant.
Results
A total of 227 patients with AIS were recruited to par-
ticipate in completing both the SRS-22r and the EQ-5D-
5L questionnaires. All the patients gave consent and
agreed on participation. Hence a total of 227 eligible pa-
tients were included in the psychometric validation of
the EQ-5D-5L. The mean age was 15.6 (±SD: 4.5) years,
74.9 % of female, and 9.7 % of severe curvature with
Cobb angle of >40°. About 62 % were under Observation
management with regular follow-up while the remaining
subjects were braced before (5.7 %), undergoing bracing
(0.8 %) and underwent surgery before (9.3 %). Baseline
characteristics of AIS patients are shown in Table 1.
Table 2 summarizes the mean, standard deviations,
floor and ceiling effects of the EQ-5D-5L and SRS-22r
subscale scores, and distribution of the EQ-5D-5L do-
main responses. No significant floor effect were ob-
served for all HRQOL scores but the EQ-5D-5L (66 %),
Function/Activity (67 %), Pain (45 %) and Mental Health
Table 1 Baseline characteristics of adolescent idiopathic
scoliosis patients
Total (N = 227)
Characteristics n %
Age (years, Mean ± SD) 15.6 ± 4.5
Gender
Male 57 25.1 %
Female 170 74.9 %
Cobb Angle 25.0 ± 11.4
≤40°, Mild or moderate 205 90.3 %
>40°, Severe 22 9.7 %
Treatment modality
Observation with regular follow-up 139 61.2 %
Braced before 13 5.7 %
Bracing 54 23.8 %
Surgery 21 9.3 %
Duration of bracing
<1 year 20 37.0 %
≥1 year 34 63.0 %
Modified Lenke Classification
Thoracic curve (Types 1/2) 86 37.9 %
Lumbar curve (Type 5) 38 16.7 %
Thoracic & Lumbar curve (Types 3/4/6) 103 45.4 %
N/n number of subjects, SD standard deviation
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(32 %) subscale scores reflected significant ceiling effect.
Over 70 % of patients perceived as “no problems” in all
EQ-5D-5L domains (70.0 - 96.3 %). No patients
responded with “extreme problems” in Mobility, Self-
care, Usual Activities, and Depression/Anxiety; and “un-
able to” in all EQ-5D-5L dimensions.
Test-retest reliability of the EQ-5D-5L and SRS-22r are
shown in Table 3. There were 20 patients who failed to
comply with telephone interviews, and one patient was
eliminated at test-retest due to the change in treatment
modality from preoperative regular follow-up to postopera-
tive hospitalization. Among 106 (83.5 %) patients assessed
in both baseline and 2-week retest interviews, the mean
interval between interviews was 19.7 days (range: 15–36
days). The ICC of the EQ-5D-5L and SRS-22r subscales
and overall scores exceeded 0.7. Agreement of the EQ-5D-
5L domain responses between two interviews ranged from
76.4 % in Pain/discomfort to 98.1 % in Self-care. Cronbach’s
alpha coefficient was 0.78 in the EQ-5D-5L score, indicat-
ing acceptable internal consistency reliability.
Table 2 Descriptive statistics of domain response and scores of the EuroQoL 5-dimension 5-level (EQ-5D-5L) and the Refined Scoli-
osis Research Society-22 (SRS-22r)
Domain/Total score Mean Standard Deviation Observed Range Theoretical Range Floor (%) Ceiling (%)
EQ-5D-5L 0.93 0.11 0.34-1.00 −0.15-1.00 0 66
SRS-22r
Function/activity 4.8 0.42 2.6-5.0 0.0-5.0 0 67
Pain 4.7 0.44 1.8-5.0 0.0-5.0 0 45
Appearance 3.9 0.64 2.0-5.0 0.0-5.0 0 9
Mental Health 4.4 0.58 2.6-5.0 0.0-5.0 0 32
Satisfaction with management 1.1 1.85 0.0-5.0 0.0-5.0 0 5
Total 4.4 0.42 2.6-5.0 0.0-5.0 0 2
EQ-5D-5L Dimension (%) No problems Slight problems Moderate problems Severe problems Unable to
Mobility 93.4 % 5.3 % 1.3 % 0.0 % 0.0 %
Self-care 96.0 % 3.1 % 0.9 % 0.0 % 0.0 %
Usual activities 85.9 % 12.8 % 1.3 % 0.0 % 0.0 %
Pain/discomfort 70.0 % 28.2 % 0.9 % 0.9 % 0.0 %
Depression/anxiety 79.3 % 17.6 % 3.1 % 0.0 % 0.0 %
Table 3 Test-retest reliability of domain and total scores of the EuroQoL 5-dimension 5-level (EQ-5D-5L) and the Refined Scoliosis
Research Society-22 (SRS-22r)
Intra-class correlation
Subscale/Total score n Estimate 95 % CI
EQ-5D-5L score 106 0.78 0.67 - 0.85
SRS-22r
Function/activity 105 0.89 0.84 - 0.92
Pain 105 0.85 0.78 - 0.90
Appearance 105 0.88 0.82 - 0.92
Mental Health 105 0.84 0.77 - 0.89
Satisfaction with management 105 0.94 0.91 - 0.96
Total 105 0.93 0.90 - 0.95
EQ-5D-5L Domain n Weighted Kappa 95 % CI Agreement
Mobility 106 .19 .08 - .29 92.5 %
Self-care 106 .66 .48 - .84 98.1 %
Usual activities 106 .52 .35 - .69 88.7 %
Pain/discomfort 106 .45 .28 - .63 76.4 %
Depression/anxiety 106 .67 .49 - .84 90.6 %
n number of subjects, CI confidence interval
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Correlations between the EQ-5D-5L domain responses
and SRS-22r domain scores are depicted in Table 4.
Those patients perceived as “no problems” in the EQ-
5D-5L domain had significantly higher Function/Activ-
ity, Pain, Appearance and total scores of the SRS-22r
than those perceived as having “any problems”. However,
those patients having “no problems” in Self-care, Usual
Activities and Pain/discomfort had significantly lower
satisfaction with management than those having “any
problems”. Furthermore, the EQ-5D-5L score had a
strong correlation with Function/Activity (r = 0.715) and
total scores (r = 0.735) of the SRS-22r, and a moderate
correlation with Pain (r = 0.594) and Appearance (r =
0.512) scores with p < 0.001.
Sensitivity of the EQ-5D-5L in differentiating known
clinical groups are displayed in Table 5. The EQ-5D-5L
and SRS-22r scores were able to detect statistical differ-
ences in treatment modalities (i.e. observation manage-
ment versus bracing or surgery, or observation
management versus bracing). Statistical differences in
the EQ-5D-5L was detected between bracing patients
with duration of less <1 year and ≥1 year but the SRS-
22r did not. Cobb angle and curve type in terms of the
modified Lenke classification were not associated with
the EQ-5D-5L and SRS-22r scores, with the exception
that the patients with severe curvature had worse mental
health than those with mild or moderate curvature. No
differences in the EQ-5D-5L and SRS-22r scores, apart
from Appearance and Satisfaction with Management,
between patients undergoing bracing and surgery were
observed.
Moreover, the profile of the studied population is pre-
sented in Table 6. The EQ-5D-5L was able to differenti-
ate patients undergoing various treatment (Observation
versus Bracing/Surgery or Observation versus Bracing),
based on the domains of Mobility, Self-care, Usual activ-
ities and Pain/discomfort (p ≤ 0.001). The EQ-5D-5L was
also able to differentiate among patients who were
undergoing bracing based on the duration of bracing,
with the most effective, significant domain being Pain/
discomfort with 70 % versus 35.3 % of patients for dur-
ation of < 1 year and ≥1 year respectively. However, the
EQ-5D-5L cannot differentiate among patients on the
basis of the pattern/type (modified Lenke classification)
and the magnitude of curvature.
Discussion
Adolescent idiopathic scoliosis is the most common
spinal abnormality in the pediatric population as seen by
pediatricians and spine surgeons [43], and it can contrib-
ute to 70 % of the structural deformities affecting the
spine in children and adolescents [44]. Adolescent idio-
pathic scoliosis patients, whether being compared to
their healthy peers or comparing among different types
Table 4 Correlation between the EuroQoL 5-dimension 5-level (EQ-5D-5L) dimension and the Refined Scoliosis Research Society-22
(SRS-22r) domain scores
SRS-22r Domain and total scores
EQ-5D-5L Domain Function/activity Pain Appearance Mental Health Satisfaction with management Total
Mean P-value Mean P-value Mean P-value Mean P-value Mean P-value Mean P-value
Mobility <0.001 <0.001 <0.001 <0.001 0.168 <0.001
No problems 4.84 4.72 3.99 4.47 1.03 4.50
Any problems 3.86 3.90 3.10 3.63 1.71 3.59
Self-care <0.001 <0.001 <0.001 <0.001 0.032 <0.001
No problems 4.81 4.69 3.96 4.45 1.02 4.47
Any problems 4.00 4.09 3.24 3.69 2.33 3.74
Usual activities <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
No problems 4.91 4.76 4.06 4.54 0.88 4.56
Any problems 3.98 4.09 3.19 3.71 2.22 3.73
Pain/discomfort <0.001 <0.001 <0.001 <0.001 0.006 <0.001
No pain/discomfort 4.91 4.81 4.07 4.56 0.85 4.58
Any pain/discomfort 4.47 4.32 3.62 4.10 1.58 4.12
Depression/anxiety <0.001 <0.001 <0.001 <0.001 0.796 <0.001
No problems 4.87 4.76 4.09 4.58 1.05 4.56
Any problems 4.42 4.31 3.34 3.80 1.13 3.96
r P-value r P-value r P-value r P-value r P-value r P-value
EQ-5D-5L Score 0.72 <0.001 0.59 <0.001 0.51 <0.001 0.57 <0.001 −0.14 0.034 0.74 <0.001
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Table 5 Sensitivity of differentiating known clinical groups
Treatment (observation versus bracing or surgery) Treatment (observation versus bracing)
Observation
(n = 139)
Bracing/Surgery
(n = 88)
Observation
(n = 139)
Bracing
(n = 67)
Mean SD Mean SD P-value* ESa Mean SD Mean SD P-value* ESa
EQ-5D-5L 0.96 0.07 0.89 0.15 <0.001 0.66 EQ-5D-5L 0.96 0.07 0.89 0.14 <0.001 0.62
SRS-22r SRS-22r
Function/activity 4.93 0.20 4.53 0.55 <0.001 0.95 Function/activity 4.93 0.20 4.58 0.50 <0.001 0.92
Pain 4.79 0.29 4.48 0.56 <0.001 0.70 Pain 4.79 0.29 4.52 0.49 <0.001 0.66
Appearance 4.03 0.55 3.78 0.74 0.004 0.39 Appearance 4.03 0.55 3.68 0.68 <0.001 0.57
Mental Health 4.49 0.51 4.31 0.67 0.028 0.29 Mental Health 4.49 0.51 4.32 0.63 0.038 0.30
Satisfaction with
management
0.25 1.02 2.37 2.01 <0.001 −1.33 Satisfaction with
management
0.25 1.02 2.13 2.01 <0.001 −1.18
Total 4.56 0.28 4.25 0.52 <0.001 0.73 Total 4.56 0.28 4.25 0.48 <0.001 0.78
Treatment (Bracing versus Surgery) Duration of Bracing
Bracing
(n = 67)
Surgery
(n = 21)
<1 year
(n = 34)
≥1 year
(n = 20)
Mean SD Mean SD P-value* ESa Mean SD Mean SD P-value* ESa
EQ-5D-5L 0.89 0.14 0.86 0.18 0.372 0.21 EQ-5D-5L 0.82 0.15 0.91 0.14 0.023 −0.66
SRS-22r SRS-22r
Function/activity 4.58 0.50 4.38 0.69 0.156 0.33 Function/activity 4.40 0.52 4.58 0.51 0.226 −0.34
Pain 4.52 0.49 4.33 0.73 0.184 0.30 Pain 4.54 0.34 4.48 0.58 0.657 0.14
Appearance 3.68 0.68 4.11 0.83 0.021 −0.56 Appearance 3.60 0.74 3.67 0.62 0.732 −0.10
Mental Health 4.32 0.63 4.30 0.83 0.924 0.02 Mental Health 4.27 0.65 4.28 0.66 0.972 −0.01
Satisfaction with
management
2.13 2.01 3.15 1.84 0.046 −0.53 Satisfaction with
management
2.43 2.12 2.52 1.96 0.875 −0.04
Total 4.25 0.48 4.25 0.67 0.991 0.002 Total 4.19 0.49 4.22 0.50 0.780 −0.08
Cobb angle (mild or moderate versus severe) Modified Lenke Classification
≤40° (n = 205) >40° (n = 20) Thoracic curve
(n = 86)
Lumbar curve
(n = 38)
Thoracic & Lumbar curve
(n = 103)
Mean SD Mean SD P-value* ESa Mean SD Mean SD Mean SD P-value*
EQ-5D-5L 0.93 0.11 0.91 0.12 0.402 0.19 EQ-5D-5L 0.92 0.13 0.93 0.11 0.95 0.10 0.271
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Table 5 Sensitivity of differentiating known clinical groups (Continued)
SRS-22r SRS-22r
Function/activity 4.78 0.41 4.69 0.52 0.349 0.20 Function/activity 4.73 0.44 4.81 0.39 4.79 0.42 0.522
Pain 4.68 0.43 4.55 0.53 0.216 0.27 Pain 4.64 0.39 4.69 0.38 4.68 0.50 0.753
Appearance 3.96 0.63 3.72 0.76 0.116 0.34 Appearance 3.94 0.70 3.84 0.58 3.97 0.61 0.583
Mental Health 4.45 0.55 4.16 0.81 0.037 0.41 Mental Health 4.41 0.62 4.36 0.61 4.45 0.55 0.703
Satisfaction with management 1.09 1.84 0.90 1.47 0.662 0.11 Satisfaction with
management
1.10 1.86 0.99 1.82 1.07 1.77 0.949
Total 4.46 0.40 4.25 0.57 0.032 0.42 Total 4.42 0.45 4.42 0.37 4.46 0.41 0.788
* P-value of independent t-test or analysis of variance test, where appropriate
aCohen’s effect size was calculated as the difference between mean scores, divided by pooled SD
N number of subjects, SD standard deviation, ES effect size
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Table 6 Correlation between the EuroQoL 5-dimension 5-level (EQ-5D-5L) Dimension and known clinical groups
Treatment (Observation versus bracing or surgery) Treatment (Observation versus bracing)
% in any problems Observation (n = 139) Bracing/Surgery (n = 88) P-value* Observation (n = 139) Bracing (n = 67) P-value*
Mobility 0.7 % 15.9 % <0.001 0.7 % 14.9 % <0.001
Self-care 0.0 % 10.2 % <0.001 0.0 % 10.4 % <0.001
Usual activities 1.4 % 34.1 % <0.001 1.4 % 34.3 % <0.001
Pain/discomfort 20.1 % 45.5 % <0.001 20.1 % 41.8 % 0.001
Depression/anxiety 18.0 % 25.0 % 0.204 18.0 % 26.9 % 0.142
Treatment (Bracing versus Surgery) Duration of Bracing
% in any problems Bracing (n = 67) Surgery (n = 21) P-value* <1 year (n = 34) ≥1 year (n = 20) P-value*
Mobility 14.9 % 19.0 % 0.652 30.0 % 11.8 % 0.096
Self-care 10.4 % 9.5 % 0.903 25.0 % 5.9 % 0.043
Usual activities 34.3 % 33.3 % 0.933 60.0 % 29.4 % 0.027
Pain/discomfort 41.8 % 57.1 % 0.218 70.0 % 35.3 % 0.014
Depression/anxiety 26.9 % 19.0 % 0.470 35.0 % 23.5 % 0.363
Cobb angle (mild or moderate versus severe) Modified Lenke Classification
% in any problems ≤40° (n = 205) >40° (n = 20) P-value* Thoracic curve (n = 86) Lumbar curve (n = 38) Thoracic & Lumbar
curve (n = 103)
P-value*
Mobility 6.3 % 9.1 % 0.622 10.5 % 2.6 % 4.9 % 0.169
Self-care 4.4 % 0.0 % 0.316 3.5 % 5.3 % 3.9 % 0.895
Usual activities 13.7 % 18.2 % 0.562 18.6 % 10.5 % 11.7 % 0.308
Pain/discomfort 29.3 % 36.4 % 0.490 32.6 % 36.8 % 25.2 % 0.328
Depression/anxiety 19.5 % 31.8 % 0.176 23.3 % 26.3 % 16.5 % 0.337
n number of subjects
Note: * P-value of Chi-square test
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of treatment, often have various aspects of their life be-
ing affected by the spine deformity. Therefore, it is desir-
able to have a reliable and suitable instrument to assess
these patients’ HRQOL. The estimated HRQOL not only
reflects the impact of AIS, it may also become part of
the basis upon which the cost-effectiveness of differen-
tial scoliosis treatment options can be evaluated.
This psychometric validation study is the first to re-
port the validity, reliability and sensitivity of the EQ-5D-
5L questionnaire in AIS patients of Chinese ethnicity.
The reliability of an instrument and whether it can re-
produce consistent results is important for the assess-
ment of the HRQOL. In this AIS population, the test-
retest reliability of the EQ-5D-5L is shown to be good,
despite having an ICC of less than that for SRS-22r. This
is accompanied by a strong agreement for all five
domains of the EQ-5D-5L (Mobility, Self-Care, Usual
Activities, Pain/Discomfort, Depression/Anxiety). Being
only a generic utility instrument of HRQOL, it is of ut-
most importance to ascertain whether the EQ-5D-5L
contains the essential elements required for the assess-
ment of the HRQOL of AIS patients. For AIS, such ele-
ments should be important for this age-group, and are
tailored for how scoliosis diseases process or presenta-
tion can affect the patients.
To substantiate the validity of the EQ-5D-5L specific-
ally for AIS, the SRS-22r was used as it is disease specific
for scoliosis and contains multiple items for contributing
to one domain score. Both the SRS-22r and EQ-5D-5L
questionnaires are commonly-used quality of life out-
come tools for patients with spinal deformity [45]. The
SRS-22r is a disease-specific outcome measure com-
monly used for effects of treatment, and it has been used
previously to assess the pre- and postoperative quality of
life of scoliosis patients and the treatment outcome of
bracing [46, 47], as well as being used in long-term
follow-up to monitor the effects of surgery versus bra-
cing over time or comparing untreated versus brace-
treated patients [11, 48]. The EQ-5D-5L, on the other
hand, is a utility measure which is more commonly used
for facilitating the calculation of QALYs. This make cost-
utility analysis and economic evaluations of healthcare in-
terventions possible, such as in the study for different
treatment for various diseases like those for rheumatoid
arthritis [49], and juvenile idiopathic arthritis [50].
In this study, not only is the EQ-5D-5L found to have
a good correlation with the overall utility score of the
SRS-22r, it is worth emphasizing that the EQ-5D-5L can
reflect upon certain aspects of the SRS-22r with signifi-
cant strength. The EQ-5D-5L has strong correlation to
the Function/Activity domain, and moderate correlations
to the Pain, Appearance and Mental Health domains of
the SRS-22r. With the EQ-5D-5L, those patients with
“no problems” in each domain scored better in the
Function/Activity, Pain and Appearance domains of the
SRS-22r than those having “any problems”, hence result-
ing in better overall SRS-22r score. Those patients with
“no problems” in the domains of Self-care, Usual Activ-
ity and Pain/Discomfort in the EQ-5D-5L are less satis-
fied with their scoliosis treatment than those patients
with “any problems”. This demonstrates that through
the SRS-22r, the EQ-5D-5L has the ability to reflect and
put into context in terms of patients’ treatment with dis-
ease presentation/symptoms, despite the absence of a
domain representing patients’ satisfaction with manage-
ment in the EQ-5D-5L. It is worth to take into account
the inherent differences of various domains being fo-
cused on by the EQ-5D-5L versus the SRS-22r, as Ap-
pearance and Satisfaction with Management in the SRS-
22r cannot have comparable items in the single-itemed,
generic the EQ-5D in general. At the same time, the vis-
ual analogue scale (VAS) of the EQ-5D does not have an
equivalent item in the SRS-22r. The VAS is a subjective
assessment of overall current health. It is of most value
when looking at changes within individuals rather than
cross-group comparisons [51], but may not produce
health state utilities for calculating QALYs [52] with
doubts in its estimation of value function [53]. Thus,
EQ5D-VAS in this case may not be of great interest as
the perception of general health of each patient varies,
and any analysis of one score given by individuals is less
conclusive as compared to the total score compounded
by the five domains covered effectively by the EQ-5D-
5L. Also, in studying ceiling effect, two-thirds (66 %)
of patients reached the EQ-5D-5L profile of ‘11111’,
suggesting a substantial ceiling effect for the EQ-5D-
5L scores. Compared with previous studies in Chinese
population, our results demonstrated a consistent pat-
tern of high ceiling effect reported in the general
population (78 %) [54] and other chronic conditions
[55–57]. Overall, the EQ-5D-5L is found to be sens-
ible and appropriate for the administration to AIS
patients, based on the above convergent validity dem-
onstrated from consideration of individual dimensions
of the instruments.
In addition, there is further investigation into
whether AIS patients with different clinical parame-
ters or severity can be detected by the EQ-5D-5L.
Both the EQ-5D-5L and SRS-22r are shown to be
sensitive in differentiating clinically known groups
who are receiving different treatment modalities.
These include comparisons between observation treat-
ment and bracing/surgery, and between observation
treatment and bracing. Furthermore, patients with the
same brace treatment can be further differentiated by
the EQ-5D-5L based on the duration of bracing (less
than or more than/equal to one year) with statistical
significance. This is not observed with the SRS-22r
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questionnaire. However, the severity of spinal curva-
tures as denoted by the magnitude of curves in Cobb
angles can only be reflected by the Mental Health
domain score of the SRS-22r being worse in severe
curvature (>40°) than the mild/moderate curves
(≤40°). Nevertheless, the overall scores of the SRS-22r
and EQ-5D-5L are not significantly different in this
AIS population, according to the type and magnitude
of curvatures. These results coincide with the findings
by Lange et al. [48], in which there were no differ-
ences in the HRQOL-scores in patients with various
types of curvature: thoracic, thoraco-lumbar, or lum-
bar major curve. As compared to the depiction by
Mental Health domain of the SRS-22r in our results,
the Self-image and Pain domain of the SRS-22 ques-
tionnaire were significantly worse in their patients
with residual large curve magnitudes, but otherwise
the reported the HRQOL was not related to curve
size [48].
The main limitation of this study is the initial test
and test-retest requiring questionnaires to be adminis-
tered in different methods (test by interviews in per-
son and retest by interviews over the phone). This is
due to the routine, regular follow-up of AIS patients
being more than two weeks apart, hence it is imprac-
tical to request patients to return in close succession
for questionnaire interviews only. However, both the
EQ-5D and SRS-22r can still have their overall scores
reproduced at an acceptable and significant level. Fi-
nally, the derivation of the EQ-5D-5L score adopts an
indirect two-step approach, rather than direct valu-
ation approach using a preference weighting of the
EQ-5D-5L value set. An indirect two-step approach
may be subject to measurement errors in the EQ-5D-
5L score, but such an approach is still the best avail-
able approach for derivation of the EQ-5D-5L scores
in Hong Kong where the cultural-specific value set is
not available.
Conclusion
The EQ-5D-5L demonstrates satisfactory psychometric
properties in terms of validity, reliability and sensitiv-
ity in Chinese patients with AIS. As the HRQOL of
adolescents can be affected to a different extent de-
pending on the presence of scoliosis, and differ
among treatment options, it is worth utilizing the
HRQOL for the assessment of the long-term outcome
of various treatment modalities and their respective
cost-effectiveness. In summary, our findings support
the applicability of the EQ-5D-5L instrument to esti-
mate the HRQOL and utility score for economic
evaluation of treatment options for AIS patients in
the future.
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